Technology
TRUE™ Tissue Technology
Our proprietary TRUE™ Tissue technology platform is currently available for investigational use only.
TRUE™ Tissue developed from cells isolated from donor tissue and is 100% biological. There are no synthetic materials or chemical fixation used, and implanted tissues are completely cell-derived and acellular.
That’s how we make tissues that are TRUE to Nature™.
Preclinical in vivo and in vitro testing has demonstrated that TRUE™ Tissue is:
- Non-calcific
- Non-immunogenic
- Regenerative
- Mechanically comparable to native tissue
- Ready to use, off-the-shelf allograft
Discover the difference TRUE™ Tissue makes as an implantable biomaterial platform. TRUE™ Tissue can be readily manufactured for a range of medical devices, implantation sites and geometries. It’s time to replace synthetic biomaterials with TRUE™ Tissue technology and enjoy the benefits of staying TRUE to Nature™.
Contact us to discuss how you can implement TRUE™ Tissue technology in the development of your medical device.
TRUE™ Vascular Graft
TRUE™ Heart Valve
TRUE™ Patch
TRUE™ Tissue Technology Pipeline
News
Vascudyne Receives BioBusiness Award from Regenerative Medicine Minnesota for Treatment of Nerve Injury
Vascudyne Announces Presentation of First Clinical Results of TRUE AVC™ in Hemodialysis Access at the VASA Conference
Regenerative Medicine Company Vascudyne Relocates to High Capacity GMP Manufacturing Facility
Vascudyne’s TRUE Tissue Technology is a Top 3 2022 Better World Project Award Finalist
Regenerative Medicine Company Vascudyne Closes $10 Million Series A Financing
Vascudyne announces successful First Human Use of TRUE™ Vascular Graft for hemodialysis access
Vascudyne’s CSO presents at the Heart Valve Society Meeting on tissue remodeling of engineered valved conduit evaluated at 52 weeks in the growing lamb
Lab-created heart valves can grow with the recipient article published in Science Translational Medicine
Proud Member of:
Copyright 2021 | Vascudyne, Inc.
